Gilead Science: Current Affairs, GK & News - 2020-2021

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

Published: June 22, 2020

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals were granted approval by the Drug Controller General of India for the production and marketing ..

Month: 

Category: 

Topics: 

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

Published: June 22, 2020

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic ..

Month: 

Category: 

Topics: 

Advertisement